| | Preface | |
| | Chloride channels in trophoblast cells cultured from human placentas / S. Byrne, S. L. Greenwood, C. P. Sibley | 3 |
| | Plasmalemma-integrated human porin discussed as part of the ORDIC channel complex / F. P. Thinnes, H. Florke, M. Heiden, U. Stadtmuller, N. Hilschmann | 9 |
| | Subcellular distribution of CFTR and lysozyme in secretory granules of tracheal gland serous cells / J. Jacquot, E. Puchelle, J. Hinnrasky, C. Fuchey, C. Bettinger, C. Spilmont, N. Bonnet, A. Dieterle, D. Dreyer, W. Dalemans, A. Pavirani | 15 |
| | Lung-specific gene therapy / J.-L. Imler, B. Bout, M. Perricaudet, G. Baskin, B. Scholte, A. Pavirani, D. Valerio | 21 |
| | Cystic fibrosis in the mouse and progress towards gene therapy / D. J. Porteous | 27 |
| | In vitro and in vivo gene transfer using DNA-liposome complexes: a study of their potential use in gene therapy for cystic fibrosis / N. J. Caplen, P. G. Middleton, K. D. Kasschau, A. D. Miller, K. I. Fasold, E. W. F. W. Alton, D. M. Geddes, C. Coutelle, R. Williamson | 33 |
| | Microbial ecology and therapy of Pseudomonas aeruginosa infection in cystic fibrosis / F. Baquero, S. Ballestero | 39 |
| | Pseudomonas aeruginosa and Pseudomonas cepacia: reservoirs, routes of transmission and their prevention / G. Doring | 49 |
| | Microbiological parameters and clinical evolution in cystic fibrosis / S. Ballestero, H. Escobar, R. Villaverde, P. Negredo, M. Elia, M. Ojeda-Vargas, F. Baquero | 55 |
| | Continuous monitoring of antimicrobial resistance in cystic fibrosis patients / S. Ballestero, H. Escobar, R. Villaverde, M. Elia, M. Ojeda-Vargas, F. Baquero | 63 |
| | Subspecific characterization (typing) of clinical isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients in Spain / M. Ojeda-Vargas, R. Alonso, A. Vindel, C. Monzon-Moreno, F. Baquero | 73 |
| | What causes respiratory exacerbations in cystic fibrosis? / A. R. Smyth, R. L. Smyth, C. A. Hart, D. P. Heaf | 79 |
| | Are some strains of Pseudomonas cepacia more contagious and more virulent than others among cystic fibrosis patients? / R. Nelson, C. O'Brien, J. R. Beesley | 85 |
| | Typing of clinical and environmental Pseudomonas cepacia isolates by pyrolysis mass spectrometry / J. T. Magee, J. Yuang, H. C. Ryley | 89 |
| | Typing of Pseudomonas cepacia isolates from Welsh CF patients by PCR of RNA ribosomal genes / H. C. Ryley, L. Millar-Jones, A. Paull, Z. Saunders | 95 |
| | Intravenous antibiotic treatment for cystic fibrosis patients: home versus hospital / D. Rogers, A. Morais, L. Millar-Jones, R. Knowles, M. C. Goodchild | 103 |
| | New trends in aerosol therapy / A. L. Smith, B. Ramsey | 109 |
| | Sputum gentamicin levels after delivery by rotahaler and nebuliser / A. Watson, M. Pond, S. Bayston, R. Booth, A. Ghonheim, S. P. Conway | 115 |
| | Enhanced liposome-mediated antibacterial activity of aminoglycoside antibiotics against Pseudomonas aeruginosa and their intratracheal delivery / H. O. Alpar, E. A. Poyner, M. R. W. Brown | 119 |
| | Meropenem for the treatment of cystic fibrosis in named patients / R. K. Knight, S. Pillai | 125 |
| | The prevalence and significance of chronic Staphylococcus aureus infection in patients with cystic fibrosis on long-term flucloxacillin / K. W. Southern, A. E. Littlewood, J. M. Littlewood | 129 |
| | Immune response in cystic fibrosis - helpful or harmful? / N. Hoiby, B. Giwercman, E. T. Jensen, H. K. Johansen, G. Kronborg, T. Pressler, A. Kharazmi | 133 |
| | Serum IgG response to Pseudomonas cepacia outer membrane antigens: assessment of cross reactivity with Pseudomonas aeruginosa / D. Lacy, A. W. Smith, D. E. Stableforth, M. R. W. Brown, P. H. Weller | 143 |
| | Long-term follow-up of anti-Pseudomonas precipitins in cystic fibrosis patients / R. Dei, S. Campana, T. Vardar, M. Russo, C. Rovai, M. Gabbrielli, C. Vuono, L. Marianelli | 147 |
| | Pseudomonas aeruginosa serology in cystic fibrosis: a comparison of methods / R. Dei, S. Campana, T. Vardar, M. Russo, M. Gabbrielli, L. Marianelli | 151 |
| | Immune response to Pseudomonas aeruginosa but not to Aspergillus fumigatus is independently correlated with pulmonary status in cystic fibrosis / C. Vazquez, J. Elorz, A. Sojo, J. C. Vitoria, M. Municio, L. Gaztelurrutia, C. Pascual | 157 |
| | Impact of neutrophil proteinases on surface antigens of T lymphocytes: evidence for in vivo cleavage / G. Doring, F. Frank, C. Boudier, G. Bellon | 163 |
| | Profile of cytokines in cystic fibrosis airways / A. Schuster, A. Haarmann, V. Wahn | 167 |
| | Present and future of pulmonary therapy for cystic fibrosis / D. V. Schidlow | 173 |
| | The value of comprehensive assessment and investigation in the management of cystic fibrosis / J. M. Littlewood | 181 |
| | Aspergillus infection in patients with cystic fibrosis following lung transplantation / B. P. Madden, C. M. Chan, K. Kamalvand, A. J. Siddiqi, P. Vuddamalay, M. E. Hodson | 189 |
| | Pulmonary function in young children with cystic fibrosis / A. Sardet, M. Boule, V. Neve, A. Baculard, G. Tournier | 197 |
| | FEV[subscript 1] trend and timing of pubertal development in patients affected by cystic fibrosis / L. Romano, S. Bonassi, A. Cohen, P. Serravalle, C. Diana, L. Minicucci, C. Romano | 201 |
| | Survey results on indication and follow-up of long-term oxygen therapy (LTOT) in cystic fibrosis centers (CF-Cs) in West Germany / M. Ballmann, V. Karsch, A. Kohlschutter | 207 |
| | Nasal intermittent positive pressure ventilation (NIPPV) for cystic fibrosis (CF) children with severe chronic respiratory failure (CRF) / A. Baculard, A. Sardet, M. Boule, B. Fauroux, G. Tournier | 213 |
| | Short- and long-term studies of rhDNase in moderately and severely affected patients with cystic fibrosis / M. E. Hodson | 219 |
| | The growing edge of lung transplantation for cystic fibrosis / B. P. Madden | 223 |
| | Short-term effect of physiotherapy on lung function and lung diffusion capacity / E. Leister, P. de Boer, M. H. Schoni | 229 |
| | Short-term effects of three chest physiotherapy regimens on patients with cystic fibrosis hospitalized for a pulmonary exacerbation: a crossover randomized study / L. M. Cappelletti, M. Cornacchia, C. Braggion, L. Zanolla, G. Mastella | 239 |
| | Nutritional support in cystic fibrosis: theoretical and practical aspects / J. Navarro, V. Varille, A. Munck | 247 |
| | The effect of nutritional status on the self-concept and body image of adolescents with cystic fibrosis / C. Snarey, A. MacDonald, G. Harris, P. Weller | 253 |
| | Bone density in adults with cystic fibrosis / E. Rietschel, Ph. Knecht, K. Scheidhauer, D. Michalk | 261 |
| | Vertebral osteopenia in cystic fibrosis / J. De Schepper, S. H. Idrissi, I. Dab, M. H. Jonckheer | 267 |
| | Bioelectrical impedance analysis for nutritional assessment in cystic fibrosis patients / M. Roulet, V. Spicher, C. Schaffner, Y. Schutz | 271 |
| | Treatment with ursodeoxycholic acid for patients with cystic fibrosis and liver disease / C. Colombo, P. M. Battezzati, B. Santini, L. Iapichino, S. Quattrucci, V. Lucidi, R. Ferrari, S. Scotta, L. Minicucci, M. Candusso, E. Valletta, R. Gagliardini, F. Santamaria, F. Battistini, N. Bettinardi, M. L. Assaisso, A. Giunta | 275 |
| | A combined approach to the evaluation of liver disease in cystic fibrosis / M. Venkataraman, P. Mansour, F. Raafat, P. John, D. A. Kelly, P. H. Weller | 281 |
| | Early detection and therapy of biliary cirrhosis in cystic fibrosis / S. Nousia-Arvanitakis, M. Fotoulaki, D. Rafailides, I. Economou, A. Makedou | 285 |
| | Potential use of a recombinant dog gastric lipase as an enzymatic supplement to pancreatic extracts in cystic fibrosis / C. Benicourt, C. Blanchard, F. Carriere, R. Verger, J.-L. Junien | 291 |
| | The outcome of pregnancy in cystic fibrosis / D. L. Smith, F. Edenborough, D. E. Stableforth | 299 |
| | Experience of the Italian register for cystic fibrosis / A. Bossi, R. Gagliardini, A. Manca, M. Zanda, A. Miano, L. Marianelli, L. Romano, A. Tedeschi, R. Padoan, V. Raia, F. Pardo, G. Grzincich, D. Salvatore, S. Quattrucci, V. Lucidi, G. de Condussio, D. Faraguna, G. Mastella, A. Giunta | 305 |
| | Reflections on one year as a young person's support worker in an Adult Cystic Fibrosis Unit / W. Baxter, D. Marks, D. Marsh, S. P. Conway | 309 |
| | Costs of cystic fibrosis (CF) and costs of screening for CF carriers in the Netherlands / J. G. Verzijl, H. B. M. Hilderink, J. B. G. M. Verheij, L. Kooij, J. D. F. Habbema, L. P. ten Kate | 313 |
| | Index of authors | 319 |
